Clinical Trial Update: A Prospective Trial of COXEN Chemotherapy Prediction [NA]

View source ↗

Summary

A prospective trial of COXEN chemotherapy prediction sponsored by the University of Virginia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer

Snippet

Sponsor: University of Virginia | Conditions: Ovarian Neoplasms, Fallopian Tube Neoplasms | NA | Status: WITHDRAWN